Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review

[1]  Jie Wu,et al.  Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis , 2020, International Journal of Gynecological Cancer.

[2]  J. D'haese,et al.  Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection. , 2019, Surgical oncology.

[3]  M. Unno,et al.  Adjuvant and neoadjuvant therapy for pancreatic cancer , 2019, Journal of Pancreatology.

[4]  J. Cameron,et al.  Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[5]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[6]  J. Cameron,et al.  Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. , 2019, Annals of surgery.

[7]  Thierry Lecomte,et al.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer , 2018, The New England journal of medicine.

[8]  J. Cameron,et al.  Isolated pulmonary recurrence following pancreatectomy for pancreatic cancer: the effect of patient factors and treatment modalities on survival , 2018, HPB.

[9]  S. Shrikhande,et al.  Improved Outcomes in 394 Pancreatic Cancer Resections: the Impact of Enhanced Recovery Pathway , 2018, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

[10]  J. Kleeff,et al.  Therapeutic developments in pancreatic cancer: current and future perspectives , 2018, Nature Reviews Gastroenterology & Hepatology.

[11]  J. Kleeff,et al.  Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders? , 2018, Annals of surgery.

[12]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[13]  T. Yamamichi,et al.  Resection for Pancreatic Cancer Lung Metastases , 2017, The Korean journal of thoracic and cardiovascular surgery.

[14]  A. Mehrabi,et al.  Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis , 2017, World journal of gastroenterology.

[15]  J. Werner,et al.  Oligometastatic Disease in Pancreatic Cancer - How to Proceed , 2017, Visceral Medicine.

[16]  M. Büchler,et al.  Radical surgery of oligometastatic pancreatic cancer , 2016 .

[17]  D. Jäger,et al.  Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients , 2016, Annals of surgery.

[18]  J. Werner,et al.  Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[19]  C. Hudis,et al.  Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients , 2016, Annals of surgery.

[20]  J. Kleeff,et al.  Pancreatic cancer , 1988, Nature Reviews Disease Primers.

[21]  R. Braren,et al.  Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience , 2015, Annals of Surgical Oncology.

[22]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[23]  David Goldstein,et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.

[24]  J. Pearson,et al.  Clinical and molecular characterization of HER2 amplified-pancreatic cancer , 2013, Genome Medicine.

[25]  Jeffrey E. Lee,et al.  Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection , 2012, Journal of Gastrointestinal Surgery.

[26]  M. Kage,et al.  Metastatic pulmonary adenocarcinoma 13 years after curative resection for pancreatic cancer: report of a case and review of Japanese literature. , 2012, JOP : Journal of the pancreas.

[27]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[28]  J. Cameron,et al.  Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival , 2011, Journal of Gastrointestinal Surgery.

[29]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[30]  Alison P. Klein,et al.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  H. Friess,et al.  Resection of Primary Pancreatic Cancer and Liver Metastasis: A Systematic Review , 2009, Digestive Surgery.

[32]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[33]  S. Fujita,et al.  Report of a case and review of the Japanese literature , 1980 .